Daclatasvir

DACLATASVIR- daclatasvir dihydrochloride tablet
Bristol-Myers Squibb Company

Storage and Handling

STORE BETWEEN 2°-25°C (36°-77°F)

FOR EXPORT DACLATASVIR DIHYDROCHLORIDE TABLET, FILM COATED
60MG/1TABLET ORAL
LIST 1304540 SAP # 1304540
CAUTION: FOR MANUFACTURING, PROCESSING, OR REPACKING. 0001
US LAW PROHIBITS DISPENSING WITHOUT PRESCRIPTION. STORE BETWEEN 2°-25°C (36°-77°F). LOT 99999 REASSAY ?????????? MFG. ???????? MFD. BY: BRISTOL-MYERS SQUIBB 4601 HIGHWAY 62 EAST MT. VERNON, IN 47620-1500

//medlibrary.org/lib/images-rx/daclatasvir/dcv-60mg-drum-lbl-300x171.jpg
(click image for full-size original)

FOR EXPORT DACLATASVIR DIHYDROCHLORIDE TABLET, FILM COATED
30MG/1TABLET ORAL
LIST 1304517 SAP # 1304517
CAUTION: FOR MANUFACTURING, PROCESSING, OR REPACKING. 0001
US LAW PROHIBITS DISPENSING WITHOUT PRESCRIPTION. STORE BETWEEN 2°-25°C (36°-77°F). LOT 99999 REASSAY ?????????? MFG. ???????? MFD. BY: BRISTOL-MYERS SQUIBB 4601 HIGHWAY 62 EAST MT. VERNON, IN 47620-1500

//medlibrary.org/lib/images-rx/daclatasvir/dcv-30mg-drum-lbl-300x171.jpg
(click image for full-size original)
DACLATASVIR
daclatasvir tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NHRIC:0087-0215
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DACLATASVIR DIHYDROCHLORIDE (DACLATASVIR) DACLATASVIR 60 mg
Inactive Ingredients
Ingredient Name Strength
ANHYDROUS LACTOSE
CELLULOSE, MICROCRYSTALLINE
CROSCARMELLOSE SODIUM
SILICON DIOXIDE
MAGNESIUM STEARATE
HYPROMELLOSES
TITANIUM DIOXIDE
POLYETHYLENE GLYCOL 400
FD&C BLUE NO. 2
INDIGOTINDISULFONATE SODIUM
ALUMINUM OXIDE
FERRIC OXIDE YELLOW
Product Characteristics
Color GREEN (Light Green) Score no score
Shape PENTAGON (5 sided) Size 9mm
Flavor Imprint Code BMS;215
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NHRIC:0087-0215-09 70000 TABLET in 1 DRUM None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Export only 11/24/2014
DACLATASVIR
daclatasvir tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NHRIC:0087-0213
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DACLATASVIR DIHYDROCHLORIDE (DACLATASVIR) DACLATASVIR 30 mg
Inactive Ingredients
Ingredient Name Strength
ANHYDROUS LACTOSE
CELLULOSE, MICROCRYSTALLINE
CROSCARMELLOSE SODIUM
SILICON DIOXIDE
MAGNESIUM STEARATE
HYPROMELLOSES
TITANIUM DIOXIDE
POLYETHYLENE GLYCOL 400
FD&C BLUE NO. 2
INDIGOTINDISULFONATE SODIUM
ALUMINUM OXIDE
FERRIC OXIDE YELLOW
Product Characteristics
Color GREEN Score no score
Shape PENTAGON (5 sided) Size 7mm
Flavor Imprint Code BMS;213
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NHRIC:0087-0213-09 150000 TABLET in 1 DRUM None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Export only 11/24/2014
Labeler — Bristol-Myers Squibb Company (938368834)

Revised: 03/2015 Bristol-Myers Squibb Company

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.